1186 Phrenic Nerve Stimulation to Improve Central Sleep Apnea and Quality of Life in Palliative Patients: A Case Report

Matthew Chaung,Andrea Nguyen,Stacy Thacker,Joyce Lee-Iannotti
DOI: https://doi.org/10.1093/sleep/zsae067.01186
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction Central sleep apnea (CSA) is a devastating disease and occurs in approximately 40% of patients with a history of stroke, neurological conditions, and heart failure(Joseph et.al). Typical symptoms include disrupted sleep or paroxysmal nocturnal hypoxemia. The gold standard for diagnosis is polysomnography and treatment is typically positive airway pressure (PAP)(Ishikawa et. al). REMEDE stimulates the phrenic nerve transvenously, providing innovative therapeutic alternatives for patients who cannot tolerate PAP therapies(Joseph et. al). Report of case(s) A 77-year-old male with history of advanced Parkinson’s disease (PD) established with palliative care, was referred to the sleep clinic for additional management of severe central sleep apnea refractory to bilevel positive airway pressure (Bilevel PAP ST). Despite initial Bilevel PAP settings of 22/18 cm of water with a backup rate of 12 bpm, the patient faced difficulties using his machine. His apnea hypopnea index (AHI) remained in the moderate range at 18 events/hour despite PAP therapy. Attempts to adjust pressure settings, implement acclimation measures, and mask changes proved unsuccessful. Due to persistent symptoms and poor quality of life (QoL), the patient was subsequently considered for phrenic nerve stimulation, meeting inclusion criteria. Six months post-implantation, he experienced significant improvement in his reported QoL (improved mood, less sleepy during the day with improved Epworth Sleepiness scores), confirmed from his wife. Unfortunately, he passed away 11 months after implantation due to PD-related complications. Conclusion Phrenic nerve stimulation emerges as a novel and effective treatment for CSA, particularly for patients intolerant to Bilevel PAP therapy. This case study highlights the positive impact of phrenic neuromodulation on QoL and sleep improvement, even in patients with palliative conditions and advanced neurodegenerative diseases. Even in patients with end-stage Parkinson disease neurosurgery to replace deep brain stimulation generators is low risk(Carlson et. al). Moreover, nutrition and swallowing can be difficult in end stage Parkinson disease and there is a role for percutaneous endoscopic gastrostomy (PEG) tube to also improve QoL(Schindler et. al). We assert that methods aimed at enhancing sleep, albeit invasive and surgical, should be considered viable options for patients categorized as palliative or terminal, with the overarching goal of improving their remaining days(Lilley et. al). Support (if any)
neurosciences,clinical neurology
What problem does this paper attempt to address?
Based on the provided text content, this paper attempts to solve the following key problems: 1. **The relationship between Leptin receptor gene variation and obesity and obstructive sleep apnea syndrome (OSA)**: - The paper explored a patient carrying a heterozygous variation in the LEPR gene (c.658G > A, resulting in p.Val220Ile amino acid substitution). This variation is related to severe obesity and may lead to the worsening of OSA. The paper pointed out that the increase in leptin levels caused by LEPR gene variation may exacerbate metabolic disorders and weight gain, further worsening OSA. - Formula representation: \[ \text{LEPR gene variation} \to \text{increase in leptin levels} \to \text{metabolic disorders} \to \text{weight gain} \to \text{worsening of OSA} \] 2. **The association between Cheyne - Stokes respiration and central sleep apnea in small lacunar infarctions**: - The paper reported an 87 - year - old male patient with severe OSA and Cheyne - Stokes respiration, and a history of transient ischemic attack and atrial fibrillation. MRI showed the presence of old small lacunar infarctions. The paper emphasized the association between small lacunar infarctions and Cheyne - Stokes respiration and central sleep apnea, especially in the absence of other clear causes. - Formula representation: \[ \text{small lacunar infarction} \to \text{Cheyne - Stokes respiration and central sleep apnea} \] 3. **Phrenic nerve stimulation in the treatment of central sleep apnea and its impact on quality of life**: - The paper introduced a 77 - year - old male patient with advanced Parkinson's disease (PD) and severe central sleep apnea, who was ineffective in treatment with bilevel positive airway pressure ventilation (Bilevel PAP ST). By implanting a phrenic nerve stimulator, the patient's sleep quality and quality of life were significantly improved. Although the patient eventually died due to PD complications, phrenic nerve stimulation showed a positive effect in improving his quality of life. - Formula representation: \[ \text{phrenic nerve stimulation} \to \text{improvement in sleep quality and quality of life} \] Overall, these papers respectively explored sleep disorder problems in different contexts, especially sleep apnea related to gene variation, cerebrovascular events and neurodegenerative diseases, and proposed new treatment methods and potential mechanisms.